Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence.
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence.
复制标题
DOI:
10.1158/2159-8290.cd-20-1375
复制
发表时间:
2021-06
期刊:
影响因子:
28.2
通讯作者:
Melnick AM
中科院分区:
文献类型:
--
作者:
Duy C;Li M;Teater M;Meydan C;Garrett-Bakelman FE;Lee TC;Chin CR;Durmaz C;Kawabata KC;Dhimolea E;Mitsiades CS;Doehner H;D'Andrea RJ;Becker MW;Paietta EM;Mason CE;Carroll M;Melnick AM
Acute myeloid leukemia (AML) patients frequently relapse after chemotherapy, yet the mechanism by which AML reemerges is not fully understood. Herein, we show that primary AML cells enter a senescence-like phenotype following chemotherapy in vitro and in vivo. This is accompanied by induction of senescence/inflammatory and embryonic diapause transcriptional programs, with downregulation of MYC and leukemia stem cell genes. Single-cell RNA-seq suggested depletion of leukemia stem cells in vitro and in vivo, and enrichment for subpopulations with distinct senescence-like cells. This senescence effect was transient and conferred superior colony forming and engraftment potential. Entry into this senescence-like phenotype was dependent on ATR, and persistence of AML cells was severely impaired by ATR inhibitors. Altogether, we propose that AML relapse is facilitated by a senescence-like resilience phenotype that occurs regardless of their stem cell status. Upon recovery, these post-senescence AML cells give rise to relapsed AMLs with increased stem cell potential.